Benign Recurrent Intrahepatic Cholestasis in Pregnancy: Fetal Death at 36 Weeks of Gestation
Author(s) -
Mariam Ayyash,
Nicolina Smith,
Madhurima Keerthy,
Ashina Singh,
Majid Shaman
Publication year - 2021
Publication title -
case reports in obstetrics and gynecology
Language(s) - English
Resource type - Journals
eISSN - 2090-6684
pISSN - 2090-6692
DOI - 10.1155/2021/5086846
Subject(s) - cholestasis of pregnancy , medicine , cholestasis , bile acid , pregnancy , gestation , gastroenterology , fetus , jaundice , obstetrics , genetics , biology
Benign recurrent intrahepatic cholestasis is a rare hepatologic disorder characterized by recurrent, self-limited episodes of severe pruritus, jaundice, and elevated bile acids. While there are guidelines for the management of intrahepatic cholestasis of pregnancy, the literature regarding benign recurrent intrahepatic cholestasis and pregnancy is limited.Case A 29-year-old G1P0 woman, with history of liver toxicity, had elevated total serum bile acid levels and liver enzymes documented at 8 weeks of gestation and throughout her pregnancy. She had a reactive nonstress test just 3 days prior to her induction. Fetal demise was noted when she presented at 36 weeks for her induction.Conclusion We recommend that women with elevated total serum bile acid early in pregnancy due to a separate entity relative to intrahepatic cholestasis of pregnancy be managed in a more individualized approach.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom